MORRISTOWN, N.J., Jan. 29, 2020 /PRNewswire/ -- Pharmacosmos Therapeutics Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Monoferric® (ferric derisomaltose) ...

Monoferric will be supplied in 100mg/mL, 500mg/5mL, and 1000mg/10mL single-dose vials for intravenous infusion after dilution. The Food and Drug Administration (FDA) has approved Monoferric (ferric ...

MORRISTOWN, N.J., Feb. 10, 2020 /PRNewswire/ -- Pharmacosmos Therapeutics Inc. announced today that it has been established as a newly formed specialty pharmaceutical company dedicated to ...

Zydus Lifesciences on Friday announced that it has entered into in-licensing agreement with Danish player Pharmacosmos A/S to market MonoFerric, or iron isomaltoside injections, in India and Nepal ...

New Delhi: Zydus Lifesciences Ltd on Friday said it has acquired rights to market MonoFerric (iron isomaltoside) injection, used to treat iron deficiency in adult patients, in India and Nepal from ...

Monoferric will be supplied in 100mg/mL, 500mg/5mL, and 1000mg/10mL single-dose vials for intravenous infusion after dilution. The Food and Drug Administration (FDA) has approved Monoferric (ferric ...